Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
Blood|September 29, 2005
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomasRoberto Piva, Roberto Chiarle, Andrea D Manazza, et al.Blood|November 9, 2002
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumorsRoberto Chiarle, Jerald Z Gong, Ilaria Guasparri, et al.Advances in Hematology|February 19, 2011
Pathobiology of anaplastic large cell lymphomaPier Paolo Piccaluga, Anna Gazzola, Claudia Mannu, et al.The American Journal of Pathology|April 12, 2002
S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phaseRoberto Chiarle, Yan Fan, Roberto Piva, et al.British Journal of Haematology|November 29, 2011
Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single arrayIvo Kwee, Andrea Rinaldi, Paola Rancoita, et al.Journal of Molecular Endocrinology|April 20, 2011
Anaplastic lymphoma kinase in human cancerAntonella Barreca, Elena Lasorsa, Ludovica Riera, et al.Cancers|January 9, 2021
NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in MelanomaValentina Audrito, Vincenzo Gianluca Messana, Enrico Moiso, et al.The EMBO Journal|May 26, 2007
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activityPaola Di Stefano, Laura Damiano, Sara Cabodi, et al.The Journal of Clinical Investigation|November 18, 2006
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genesRoberto Piva, Elisa Pellegrino, Michela Mattioli, et al.International Journal of Molecular Sciences|April 12, 2022
Hypermethylation-Mediated Silencing of CIDEA, MAL and PCDH17 Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic StudiesEleonora Zorzan, Ramy Elgendy, Giorgia Guerra, et al.Pageof 8